A citation-based method for searching scientific literature

Maya Amitai, Michal Taler, Maya Lebow, Reut Ben-Baruch, Alan Apter, Silvana Fennig, Abraham Weizman, Alon Chen. Eur Neuropsychopharmacol 2020
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity





Impact of physical and sexual abuse on treatment response in the Treatment of Resistant Depression in Adolescent Study (TORDIA).
Wael Shamseddeen, Joan Rosenbaum Asarnow, Gregory Clarke, Benedetto Vitiello, Karen Dineen Wagner, Boris Birmaher, Martin B Keller, Graham Emslie, Satish Iyengar, Neal D Ryan,[...]. J Am Acad Child Adolesc Psychiatry 2011
50
50

The Effect of Depression, Generalized Anxiety, and Selective Serotonin Reuptake Inhibitors on Change in Bone Metabolism in Adolescents and Emerging Adults.
Chadi A Calarge, James A Mills, Kathleen F Janz, Trudy L Burns, Janet A Schlechte, William H Coryell, Babette S Zemel. J Bone Miner Res 2017
12
50

Additive effects of 5-HTTLPR (serotonin transporter) and tryptophan hydroxylase 2 G-703T gene polymorphisms on the clinical response to citalopram among children and adolescents with depression and anxiety disorders.
Benyamin Rotberg, Sefi Kronenberg, Miri Carmel, Amos Frisch, David Brent, Gil Zalsman, Alan Apter, Abraham Weizman. J Child Adolesc Psychopharmacol 2013
15
50

Neural Reactivity to Angry Faces Predicts Treatment Response in Pediatric Anxiety.
Nora Bunford, Autumn Kujawa, Kate D Fitzgerald, James E Swain, Gregory L Hanna, Elizabeth Koschmann, David Simpson, Sucheta Connolly, Christopher S Monk, K Luan Phan. J Abnorm Child Psychol 2017
18
50

Suicidal events in the Treatment for Adolescents With Depression Study (TADS).
Benedetto Vitiello, Susan G Silva, Paul Rohde, Christopher J Kratochvil, Betsy D Kennard, Mark A Reinecke, Taryn L Mayes, Kelly Posner, Diane E May, John S March. J Clin Psychiatry 2009
66
50

Modulation of frontostriatal interaction aligns with reduced primary reward processing under serotonergic drugs.
Birgit Abler, Georg Grön, Antonie Hartmann, Coraline Metzger, Martin Walter. J Neurosci 2012
45
50

Association of regulatory TPH2 polymorphisms with higher reduction in depressive symptoms in children and adolescents treated with fluoxetine.
Patricia Gassó, Natalia Rodríguez, Daniel Boloc, Ana Blázquez, Teresa Torres, Ana Gortat, Maria Teresa Plana, Amalia Lafuente, Sergi Mas, Joan Albert Arnaiz,[...]. Prog Neuropsychopharmacol Biol Psychiatry 2017
8
50

Treated depression in adolescents: predictors of outcome at 28 weeks.
Paul Wilkinson, Bernadka Dubicka, Raphael Kelvin, Chris Roberts, Ian Goodyer. Br J Psychiatry 2009
31
50

The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: A review.
J D A Olivier, T Blom, T Arentsen, J R Homberg. Prog Neuropsychopharmacol Biol Psychiatry 2011
87
50

Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Andrea Cipriani, Xinyu Zhou, Cinzia Del Giovane, Sarah E Hetrick, Bin Qin, Craig Whittington, David Coghill, Yuqing Zhang, Philip Hazell, Stefan Leucht,[...]. Lancet 2016
262
50

Cortical thickening in remitters compared to non-remitters with major depressive disorder following 8-week antidepressant treatment.
A Saricicek Aydogan, E Oztekin, M E Esen, S Dusmez, F Gelal, L Besiroğlu, N Zorlu. Acta Psychiatr Scand 2019
5
50

Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment.
Katharine Boaden, Anneka Tomlinson, Samuele Cortese, Andrea Cipriani. Front Psychiatry 2020
3
50

Secondary Outcomes From the Child/Adolescent Anxiety Multimodal Study: Implications for Clinical Practice.
Anne Marie Albano, Jonathan S Comer, Scott N Compton, John Piacentini, Philip C Kendall, Boris Birmaher, John T Walkup, Golda S Ginsburg, Moira A Rynn, James McCracken,[...]. Evid Based Pract Child Adolesc Ment Health 2018
8
50

Recovery and recurrence following treatment for adolescent major depression.
John Curry, Susan Silva, Paul Rohde, Golda Ginsburg, Christopher Kratochvil, Anne Simons, Jerry Kirchner, Diane May, Betsy Kennard, Taryn Mayes,[...]. Arch Gen Psychiatry 2011
110
50


Development and validation of a prediction model for the probability of responding to placebo in antidepressant trials: a pooled analysis of individual patient data.
Kiyomi Shinohara, Shiro Tanaka, Hissei Imai, Hisashi Noma, Kazushi Maruo, Andrea Cipriani, Shigeto Yamawaki, Toshi A Furukawa. Evid Based Ment Health 2019
6
50

Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression.
B R Godlewska, M Browning, R Norbury, P J Cowen, C J Harmer. Transl Psychiatry 2016
57
50

Adolescents' attitudes and opinions about depression treatment.
Kristina L Bradley, Patrick J McGrath, Cyndi L Brannen, Alexa L Bagnell. Community Ment Health J 2010
24
50

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
Jeffrey H Meyer, Alan A Wilson, Sandra Sagrati, Doug Hussey, Anna Carella, William Z Potter, Nathalie Ginovart, Edgar P Spencer, Andy Cheok, Sylvain Houle. Am J Psychiatry 2004
339
50

Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study.
Christine Y Lu, Fang Zhang, Matthew D Lakoma, Jeanne M Madden, Donna Rusinak, Robert B Penfold, Gregory Simon, Brian K Ahmedani, Gregory Clarke, Enid M Hunkeler,[...]. BMJ 2014
112
50



Trajectories of Functioning Into Emerging Adulthood Following Treatment for Adolescent Depression.
Amy T Peters, Rachel H Jacobs, Claudia Feldhaus, David B Henry, Anne Marie Albano, Scott A Langenecker, Mark A Reinecke, Susan G Silva, John F Curry. J Adolesc Health 2016
12
50

Navigating the Social Environment in Adolescence: The Role of Social Brain Development.
Jack L Andrews, Saz P Ahmed, Sarah-Jayne Blakemore. Biol Psychiatry 2021
7
50

Nocebo effect in randomized clinical trials of antidepressants in children and adolescents: systematic review and meta-analysis.
Johanna Carolina Rojas-Mirquez, Milton Jose Max Rodriguez-Zuñiga, Francisco Javier Bonilla-Escobar, Herney Andres Garcia-Perdomo, Mike Petkov, Lino Becerra, David Borsook, Clas Linnman. Front Behav Neurosci 2014
20
50

Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents.
Jenny W Sun, Sonia Hernández-Díaz, Sebastien Haneuse, Florence T Bourgeois, Seanna M Vine, Mark Olfson, Brian T Bateman, Krista F Huybrechts. JAMA Psychiatry 2021
3
50

The bi-directional relationship between parent-child conflict and treatment outcome in treatment-resistant adolescent depression.
Manivel Rengasamy, Brandon M Mansoor, Robert Hilton, Giovanna Porta, Jiayan He, Graham J Emslie, Taryn Mayes, Gregory N Clarke, Karen Dineen Wagner, Martin B Keller,[...]. J Am Acad Child Adolesc Psychiatry 2013
20
50

Association between irritability and suicidal ideation in three clinical trials of adults with major depressive disorder.
Manish K Jha, Abu Minhajuddin, Cherise Chin Fatt, Katharina Kircanski, Argyris Stringaris, Ellen Leibenluft, Madhukar H Trivedi. Neuropsychopharmacology 2020
4
50

Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents.
Mary Nilsson, Melissa J Joliat, Cherri M Miner, Eileen B Brown, John H Heiligenstein. J Child Adolesc Psychopharmacol 2004
26
50


Do antidepressants precipitate youth suicide?: a nationwide pharmacoepidemiological study.
Lars Søndergård, Kajsa Kvist, Per K Andersen, Lars V Kessing. Eur Child Adolesc Psychiatry 2006
38
50

fMRI predictors of treatment outcome in pediatric anxiety disorders.
Erin B McClure, Abby Adler, Christopher S Monk, Jennifer Cameron, Samantha Smith, Eric E Nelson, Ellen Leibenluft, Monique Ernst, Daniel S Pine. Psychopharmacology (Berl) 2007
105
50

Predictors of remission with placebo using an integrated study database from patients with major depressive disorder.
J C Nelson, Q Zhang, W Deberdt, L B Marangell, O Karamustafalioglu, I A Lipkovich. Curr Med Res Opin 2012
24
50

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
Christopher G Davey, Andrew M Chanen, Sarah E Hetrick, Sue M Cotton, Aswin Ratheesh, Günter P Amminger, John Koutsogiannis, Mark Phelan, Edward Mullen, Ben J Harrison,[...]. Lancet Psychiatry 2019
21
50

A single dose of fluoxetine reduces neural limbic responses to anger in depressed adolescents.
Liliana P Capitão, Robert Chapman, Susannah E Murphy, Christopher-James Harvey, Anthony James, Philip J Cowen, Catherine J Harmer. Transl Psychiatry 2019
7
50

Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis.
Eric T Dobson, Michael H Bloch, Jeffrey R Strawn. J Clin Psychiatry 2019
19
50

Early changes of serum BDNF and SSRI response in adolescents with major depressive disorder.
Jung Lee, Kyung Hwa Lee, Seong Hae Kim, Ji Youn Han, Soon-Beom Hong, Soo-Churl Cho, Jae-Won Kim, David Brent. J Affect Disord 2020
5
50

Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study.
Heather D Anderson, Wilson D Pace, Anne M Libby, David R West, Robert J Valuck. Clin Ther 2012
68
50

Mediators of youth anxiety outcomes 3 to 12 years after treatment.
Heather B Makover, Philip C Kendall, Thomas Olino, Matthew M Carper, Anne Marie Albano, John Piacentini, Tara Peris, Audra K Langley, Araceli Gonzalez, Golda S Ginsburg,[...]. J Anxiety Disord 2020
1
100

Anterior cingulate activation to implicit threat before and after treatment for pediatric anxiety disorders.
Katie L Burkhouse, Autumn Kujawa, Bobby Hosseini, Heide Klumpp, Kate D Fitzgerald, Scott A Langenecker, Christopher S Monk, K Luan Phan. Prog Neuropsychopharmacol Biol Psychiatry 2018
10
50


Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
Georgina R Cox, Patch Callahan, Rachel Churchill, Vivien Hunot, Sally N Merry, Alexandra G Parker, Sarah E Hetrick. Cochrane Database Syst Rev 2014
62
50

State-dependent changes in hippocampal grey matter in depression.
D Arnone, S McKie, R Elliott, G Juhasz, E J Thomas, D Downey, S Williams, J F W Deakin, I M Anderson. Mol Psychiatry 2013
161
50

Sleep-related problems among children and adolescents with anxiety disorders.
Candice A Alfano, Golda S Ginsburg, Julie Newman Kingery. J Am Acad Child Adolesc Psychiatry 2007
184
50

Acute fluoxetine modulates emotional processing in young adult volunteers.
L P Capitão, S E Murphy, M Browning, P J Cowen, C J Harmer. Psychol Med 2015
16
50

Distress, quality of life and disability in treatment-seeking young adults with social anxiety disorder.
Shin Ho Park, Yun Ju C Song, Eleni A Demetriou, Karen L Pepper, Ian B Hickie, Nick Glozier, Daniel F Hermens, Elizabeth M Scott, Adam J Guastella. Early Interv Psychiatry 2021
1
100

Increased circulatory IL-6 during 8-week fluoxetine treatment is a risk factor for suicidal behaviors in youth.
Maya Amitai, Michal Taler, Reut Ben-Baruch, Maya Lebow, Ron Rotkopf, Alan Apter, Silvana Fennig, Abraham Weizman, Alon Chen. Brain Behav Immun 2020
6
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.